Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Dobashi

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Respiratory Medicine|December 3, 1999
A case of non-specific interstitial pneumonia associated with primary lung cancer: possible role of antibodies to lung cancer cells in the pathogenesis of non-specific interstitial pneumoniaI Yamadori, T Sato, J Fujita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1993
[Spontaneous splenic rupture in a case of non-Hodgkin's lymphoma]N Dobashi, Y Kuraishi, T Kobayashi, et al.
Masui. the Japanese Journal of Anesthesiology|January 1, 1990
[Anesthetic experience of a patient with essential thrombocythemia]N Kotani, T Sakai, S Ohshima, et al.
The European Respiratory Journal|October 30, 1999
Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumoniaN Dobashi, J Fujita, Y Ohtsuki, et al.
British Journal of Cancer|November 11, 1999
Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell linesJ Fujita, N Dobashi, Y Ohtsuki, et al.
Masui. the Japanese Journal of Anesthesiology|June 1, 1990
[Respiratory gas exchange during total body hyperthermia in man]H Ishihara, F Tanioka, T Iida, et al.
International Journal of Cancer|June 11, 1999
Expression of cytokeratin 19 mRNA in human lung cancer cell linesY Ueda, J Fujita, S Bandoh, et al.
The Journal of Rheumatology|November 11, 1999
Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositisJ Fujita, N Dobashi, M Tokuda, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2001
Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significanceT Nagai, M Murota, M Nishioka, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2000
Mechanisms of the release of CYFRA21-1 in human lung cancer cell linesK Dohmoto, S Hojo, J Fujita, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Respiratory Medicine|December 3, 1999
A case of non-specific interstitial pneumonia associated with primary lung cancer: possible role of antibodies to lung cancer cells in the pathogenesis of non-specific interstitial pneumoniaI Yamadori, T Sato, J Fujita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1993
[Spontaneous splenic rupture in a case of non-Hodgkin's lymphoma]N Dobashi, Y Kuraishi, T Kobayashi, et al.
Masui. the Japanese Journal of Anesthesiology|January 1, 1990
[Anesthetic experience of a patient with essential thrombocythemia]N Kotani, T Sakai, S Ohshima, et al.
The European Respiratory Journal|October 30, 1999
Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumoniaN Dobashi, J Fujita, Y Ohtsuki, et al.
British Journal of Cancer|November 11, 1999
Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell linesJ Fujita, N Dobashi, Y Ohtsuki, et al.
Masui. the Japanese Journal of Anesthesiology|June 1, 1990
[Respiratory gas exchange during total body hyperthermia in man]H Ishihara, F Tanioka, T Iida, et al.
International Journal of Cancer|June 11, 1999
Expression of cytokeratin 19 mRNA in human lung cancer cell linesY Ueda, J Fujita, S Bandoh, et al.
The Journal of Rheumatology|November 11, 1999
Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositisJ Fujita, N Dobashi, M Tokuda, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2001
Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significanceT Nagai, M Murota, M Nishioka, et al.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2000
Mechanisms of the release of CYFRA21-1 in human lung cancer cell linesK Dohmoto, S Hojo, J Fujita, et al.
Pageof 4